Clinical Trial Update: Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and tolerability of IMM01-STEM in patients with muscle atrophy related to knee osteoarthritis; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Muscle Atrophy

Drugs mentioned

• IMM01-STEM

Snippet

Sponsor: Immunis, Inc. | Conditions: Muscle Atrophy | Phase 1, Phase 2 | Status: RECRUITING